Cloud Pharmaceuticals works with partners at all stages of drug development including early stage, preclinical, IND, and the clinic. We are currently engaged in drug discovery and development programs spanning a wide range of indications including:
- Autism, Alzheimer's, and other neurodegenerative disorders
- Cancer, solid tumor and hematologic, including lymphoma, fibrosis, blood cancers, lung cancer, etc.
- Inflammation, rheumatoid arthritis, sarcopenia
- Kidney disease
- Orphan diseases including malaria, Dengue fever, and Chagas disease
- Metabolic disorders, lipid metabolism, etc.
- Respiratory diseases and chronic obstructive pulmonary disease (COPD)